Phoenixin 14 Inhibits High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Experimental Mice

Phoenixin 14 Inhibits High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Experimental Mice

Fan Yang,1 Ping Huang,1 Liandong Shi,2 Feng Liu,3 Aimei Tang,3 Shaohui Xu1 1Department of Endocrinology, Guilin People’s Hospital, Guilin, Guangxi 541002, People’s Republic of China; 2Department of Ultrasonography, Guilin People’s Hospital, Guilin, Guangxi 541002, Peopl...

Full description

Bibliographic Details
Main Authors:	Yang F, Huang P, Shi L, Liu F, Tang A, Xu S
Format:	Article
Language:	English
Published:	Dove Medical Press 2020-09-01
Series:	Drug Design, Development and Therapy
Subjects:	phoenixin 14 nonalcoholic fatty liver disease (nafld) oxidative stress inflammation nrf2/ho-1 sirt1/ampk
Online Access:	https://www.dovepress.com/phoenixin-14-inhibits-high-fat-diet-induced-non-alcoholic-fatty-liver--peer-reviewed-article-DDDT

Similar Items

Phoenixin—A Pleiotropic Gut-Brain Peptide
by: Martha A. Schalla, et al.
Published: (2018-06-01)

Role of the Novel Peptide Phoenixin in Stress Response and Possible Interactions with Nesfatin-1
by: Tiemo Friedrich, et al.
Published: (2021-08-01)

Phoenixin: More than Reproductive Peptide
by: Maria Billert, et al.
Published: (2020-11-01)

Phoenixin Expression Is Regulated by the Fatty Acids Palmitate, Docosahexaenoic Acid and Oleate, and the Endocrine Disrupting Chemical Bisphenol A in Immortalized Hypothalamic Neurons
by: Emma K. McIlwraith, et al.
Published: (2018-11-01)

Inhibition of NAMPT aggravates high fat diet-induced hepatic steatosis in mice through regulating Sirt1/AMPKα/SREBP1 signaling pathway
by: Ling-Fang Wang, et al.
Published: (2017-04-01)

Sleeve gastrectomy ameliorated high-fat diet (HFD)-induced non-alcoholic fatty liver disease and upregulated the nicotinamide adenine dinucleotide +/ Sirtuin-1 pathway in mice
by: Rong Hua, et al.
Published: (2021-01-01)

The NAD salvage pathway during the progression of non-alcoholic fatty liver disease
by: Penke, Melanie
Published: (2016)

AMPK Re-Activation Suppresses Hepatic Steatosis but its Downregulation Does Not Promote Fatty Liver Development
by: Nadia Boudaba, et al.
Published: (2018-02-01)

N-Acetyl Cysteine Ameliorates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease and Intracellular Triglyceride Accumulation by Preserving Mitochondrial Function
by: Weijian Hang, et al.
Published: (2021-09-01)

Involvement of HO-1 and Autophagy in the Protective Effect of Magnolol in Hepatic Steatosis-Induced NLRP3 Inflammasome Activation In Vivo and In Vitro
by: Ni-Chun Kuo, et al.
Published: (2020-09-01)

Protective effect of celastrol on type 2 diabetes mellitus with nonalcoholic fatty liver disease in mice
by: JuanJuan Sun, et al.
Published: (2020-11-01)

Relationship between Non-Alcoholic Fatty Liver Disease and Psoriasis: A Novel Hepato-Dermal Axis?
by: Alessandro Mantovani, et al.
Published: (2016-02-01)

Hepatic LKB1 Reduces the Progression of Non-Alcoholic Fatty Liver Disease via Genomic Androgen Receptor Signaling
by: Jun H. Heo, et al.
Published: (2021-07-01)

Non-Alcoholic Fatty Liver Disease Molecular Bases, Prevention and Treatment
Published: (2018)

Silibinin Restores NAD+ Levels and Induces the SIRT1/AMPK Pathway in Non-Alcoholic Fatty Liver
by: Federico Salomone, et al.
Published: (2017-09-01)

Gender effect of hyperuricemia on the development of nonalcoholic fatty liver disease (NAFLD): A clinical analysis and mechanistic study
by: Keyang Xu, et al.
Published: (2019-09-01)

Natural Product Heme Oxygenase Inducers as Treatment for Nonalcoholic Fatty Liver Disease
by: David E. Stec, et al.
Published: (2020-12-01)

Involvement of the Autophagy-ER Stress Axis in High Fat/Carbohydrate Diet-Induced Nonalcoholic Fatty Liver Disease
by: Xiu Zhou, et al.
Published: (2020-08-01)

Ginsenoside Rg1 ameliorates cardiac oxidative stress and inflammation in streptozotocin-induced diabetic rats
by: Qin Q, et al.
Published: (2019-07-01)

Treating hyperuricemia related non-alcoholic fatty liver disease in rats with resveratrol
by: Keyang Xu, et al.
Published: (2019-02-01)

Exploring the Protective Effects and Mechanism of Crocetin From Saffron Against NAFLD by Network Pharmacology and Experimental Validation
by: Zijin Xu, et al.
Published: (2021-06-01)

Serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease
by: Min-Sun Kwak, et al.
Published: (2012-12-01)

Effects of Mogrosides on High-Fat-Diet-Induced Obesity and Nonalcoholic Fatty Liver Disease in Mice
by: Xiaobing Zhang, et al.
Published: (2018-07-01)

3,5-Dicaffeoylquinic Acid Lowers 3T3-L1 Mitotic Clonal Expansion and Adipocyte Differentiation by Enhancing Heme Oxygenase-1 Expression
by: Alice Raineri, et al.
Published: (2021-08-01)

Role of Mitochondria in Nonalcoholic Fatty Liver Disease
by: Fatiha Nassir, et al.
Published: (2014-05-01)

Evaluation of potential gene expression as early markers of insulin resistance and non-alcoholic fatty liver disease in the Indonesian population
by: Eunice Limantara, et al.
Published: (2018-12-01)

The Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver Disease
by: Umair Iqbal, et al.
Published: (2019-03-01)

Foie gras and liver regeneration: a fat dilemma
by: Maria Agnese Della Fazia, et al.
Published: (2018-06-01)

Microbial Intervention as a Novel Target in Treatment of Non-Alcoholic Fatty Liver Disease Progression
by: Youlian Zhou, et al.
Published: (2018-12-01)

Diosgenin ameliorates palmitic acid-induced lipid accumulation via AMPK/ACC/CPT-1A and SREBP-1c/FAS signaling pathways in LO2 cells
by: Ke Fang, et al.
Published: (2019-09-01)

Comparison of liver enzymes and sonological grading in nonalcoholic fatty liver
by: Bishnu Jwarchan, et al.
Published: (2020-03-01)

Connection Between Non-Alcoholic Fatty Liver Disease and Diabetes Mellitus
by: Oprea-Călin Gabriela, et al.
Published: (2014-06-01)

Fructose, Omega 3 Fatty Acids, and Vitamin E: Involvement in Pediatric Non-Alcoholic Fatty Liver Disease
by: Gigliola Alberti, et al.
Published: (2020-11-01)

Flavonones from Penthorum chinense Ameliorate Hepatic Steatosis by Activating the SIRT1/AMPK Pathway in HepG2 Cells
by: Wei-Wei Guo, et al.
Published: (2018-08-01)

Fisetin Protects Against Hepatic Steatosis Through Regulation of the Sirt1/AMPK and Fatty Acid β-Oxidation Signaling Pathway in High-Fat Diet-Induced Obese Mice
by: Chian-Jiun Liou, et al.
Published: (2018-09-01)

Hypothyroidism-Induced Nonalcoholic Fatty Liver Disease (HIN): Mechanisms and Emerging Therapeutic Options
by: Daniela Maria Tanase, et al.
Published: (2020-08-01)

Radix Polygoni Multiflori and Its Main Component Emodin Attenuate Non-Alcoholic Fatty Liver Disease in Zebrafish by Regulation of AMPK Signaling Pathway
by: Yu L, et al.
Published: (2020-04-01)

Latin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease
by: Juan Pablo Arab, et al.
Published: (2020-11-01)

Protective Effects of Licochalcone A Ameliorates Obesity and Non-Alcoholic Fatty Liver Disease Via Promotion of the Sirt-1/AMPK Pathway in Mice Fed a High-Fat Diet
by: Chian-Jiun Liou, et al.
Published: (2019-05-01)

Exercise and dietary intervention ameliorate high-fat diet-induced NAFLD and liver aging by inducing lipophagy
by: Yu Gao, et al.
Published: (2020-09-01)